Synopsis: Transcranial Magnetic Stimulation (TMS) therapy, one of the most effective treatments for major depression, has been FDA approved for adults for 14 years. The FDA has not yet approved TMS for adolescent depression even though they approved a TMS device for migraine headaches in children. This article reviews research that shows TMS for adolescent depression to be safe, feasible, and effective.

BY LEN LANTZ, MD / 1.26.22; No. 55 / 9 min read

This article has been archived as it no longer has current information due to the FDA’s 3/22/24 approval of TMS therapy for adolescent depression. For a more recent article on TMS for adolescent depression, please see my article titled, “A New Treatment for Adolescent Depression: FDA Approves Transcranial Magnetic Stimulation (TMS).”